Dermatitis  >>  betamethasone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
betamethasone / Generic mfg.
NCT01033097 / 2009-012098-36: Safety and Efficacy of DNK333 in Atopic Dermatitis Patients

Completed
2
80
Europe
DNK333 5 mg, Placebo to 5 mg, DNK333 25 mg, Placebo to 25 mg, DNK333 100 mg, Placebo to 100 mg, Betamethasone 4 mg, DNK333 1mg, Placebo to 1mg
Novartis Pharmaceuticals
Pruritus in Patients With Atopic Dermatitis
07/11
07/11

Download Options